This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: The Multiple Myeloma Research Foundation, Inc.. Active years: 2020-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2021
Title: Kathryn E. Giusti: Innovator in Multiple Myeloma Research
Introduction
Kathryn E. Giusti is a prominent inventor based in New Canaan, CT (US). She has made significant contributions to the field of medical research, particularly in the area of multiple myeloma. With a total of 2 patents, her work focuses on integrating various data systems to enhance patient care and research outcomes.
Latest Patents
Giusti's latest patents include an innovative integrated molecular, omics, immunotherapy, metabolic, epigenetic, and clinical database. This patent describes a patient registry data system that aggregates clinical, molecular, and immune parameters involved in disease initiation, progression, and response to treatment. The system allows participants, researchers, and physicians to visualize data based on parameters such as participant demographics and immune system data. Additionally, she has developed methods for data collection and distribution, which incentivize research participation through early access to collected data and samples.
Career Highlights
Giusti is currently associated with the Multiple Myeloma Research Foundation, Inc., where she continues to drive advancements in the understanding and treatment of multiple myeloma. Her work has been instrumental in bridging the gap between clinical research and patient care.
Collaborations
Some of her notable coworkers include Daniel Auclair and Paul Giusti, who collaborate with her in various research initiatives aimed at improving outcomes for multiple myeloma patients.
Conclusion
Kathryn E. Giusti's innovative work and patents reflect her commitment to enhancing the landscape of multiple myeloma research. Her contributions are paving the way for better patient outcomes and a deeper understanding of the disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile